Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05954143 |
|---|---|
| Brief Title: | Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer |
| First Submitted : | June 23, 2023 |
| First Submitted that Met QC Criteria : | July 12, 2023 |
| First Posted : | July 20, 2023 |
| Last Update Submitted that Met QC Criteria : | February 14, 2024 |
| Last Update Posted : | February 15, 2024 |